David Hubbard

802 total citations
10 papers, 632 citations indexed

About

David Hubbard is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Social Psychology. According to data from OpenAlex, David Hubbard has authored 10 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 5 papers in Behavioral Neuroscience and 4 papers in Social Psychology. Recurrent topics in David Hubbard's work include Stress Responses and Cortisol (5 papers), Neuroendocrine regulation and behavior (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). David Hubbard is often cited by papers focused on Stress Responses and Cortisol (5 papers), Neuroendocrine regulation and behavior (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). David Hubbard collaborates with scholars based in United States, Sweden and Guam. David Hubbard's co-authors include Chris Markham, D. Caroline Blanchard, Robert J. Blanchard, Mu Yang, Lorey K. Takahashi, Krista McFarland, L.K. Takahashi, Jian‐Nong Ma, Tracy A. Spalding and Ethan S. Burstein and has published in prestigious journals such as Neuroscience, Physiology & Behavior and Behavioral Neuroscience.

In The Last Decade

David Hubbard

10 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hubbard United States 9 298 228 220 200 124 10 632
Karin J. Wallace United Kingdom 10 266 0.9× 251 1.1× 279 1.3× 316 1.6× 217 1.8× 11 732
S. Michalíková United Kingdom 11 156 0.5× 172 0.8× 243 1.1× 176 0.9× 51 0.4× 14 625
Pierre Chapillon France 13 351 1.2× 345 1.5× 234 1.1× 185 0.9× 45 0.4× 21 860
P.S. Mabbutt United Kingdom 12 207 0.7× 237 1.0× 358 1.6× 217 1.1× 72 0.6× 17 663
Mark Hebert United States 16 321 1.1× 311 1.4× 262 1.2× 173 0.9× 34 0.3× 27 722
Claudia F. Plappert Germany 15 146 0.5× 127 0.6× 311 1.4× 216 1.1× 79 0.6× 33 708
Marisol R. Lamprea Colombia 13 135 0.5× 143 0.6× 209 0.9× 196 1.0× 48 0.4× 33 522
et al United States 12 304 1.0× 159 0.7× 312 1.4× 260 1.3× 122 1.0× 15 797
Jolanta Zagrodzka Poland 12 288 1.0× 236 1.0× 171 0.8× 147 0.7× 29 0.2× 28 573
Philip M. Wall Canada 11 212 0.7× 219 1.0× 336 1.5× 190 0.9× 26 0.2× 12 670

Countries citing papers authored by David Hubbard

Since Specialization
Citations

This map shows the geographic impact of David Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hubbard more than expected).

Fields of papers citing papers by David Hubbard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hubbard. The network helps show where David Hubbard may publish in the future.

Co-authorship network of co-authors of David Hubbard

This figure shows the co-authorship network connecting the top 25 collaborators of David Hubbard. A scholar is included among the top collaborators of David Hubbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hubbard. David Hubbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hubbard, David, Uli Hacksell, & Krista McFarland. (2013). Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson’s disease and Parkinson’s disease psychosis. Behavioural Pharmacology. 24(7). 628–632. 17 indexed citations
2.
McFarland, Krista, Tracy A. Spalding, David Hubbard, et al.. (2013). Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson’s Disease. ACS Chemical Neuroscience. 4(11). 1430–1438. 100 indexed citations
3.
Kesby, James P., David Hubbard, Athina Markou, & Svetlana Semenova. (2012). Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. Addiction Biology. 19(4). 593–605. 23 indexed citations
4.
Hubbard, David, et al.. (2007). Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience. 150(4). 818–828. 72 indexed citations
5.
Takahashi, Lorey K., et al.. (2007). Predator odor-induced conditioned fear involves the basolateral and medial amygdala.. Behavioral Neuroscience. 121(1). 100–110. 70 indexed citations
6.
Yang, Mu, Hanna Augustsson, Chris Markham, et al.. (2004). The rat exposure test: a model of mouse defensive behaviors. Physiology & Behavior. 81(3). 465–473. 103 indexed citations
7.
Hubbard, David, et al.. (2003). Development of defensive behavior and conditioning to cat odor in the rat. Physiology & Behavior. 80(4). 525–530. 73 indexed citations
8.
Blanchard, D. Caroline, et al.. (2003). Failure to produce conditioning with low-dose trimethylthiazoline or cat feces as unconditioned stimuli.. Behavioral Neuroscience. 117(2). 360–368. 93 indexed citations
9.
Blanchard, D. Caroline, David Hubbard, Chris Markham, et al.. (2003). Dorsal premammillary nucleus differentially modulates defensive behaviors induced by different threat stimuli in rats. Neuroscience Letters. 345(3). 145–148. 73 indexed citations
10.
Reinitz, Elizabeth, David Hubbard, & Arthur I. Grayzel. (1982). Central nervous system systemic lupus erythematosus versus central nervous system infection: low cerebral spinal fluid glucose and pleocytosis in a patient with a prolonged course. Arthritis & Rheumatism. 25(5). 583–587. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026